Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Vita Coco Company Inc (COCO) vs Sana Biotechnology Inc (SANA) Price & Performance

The Vita Coco Company IncTrade
Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

The Vita Coco Company Inc vs Sana Biotechnology Inc — how do they compare? The Vita Coco Company Inc trades at $74.45 (market cap $4.23B), while Sana Biotechnology Inc trades at $3.58 (market cap $994.89M). The key difference: The Vita Coco Company Inc is far larger — about 4.3× Sana Biotechnology Inc's market cap, and The Vita Coco Company Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.

COCOSANA
Market Cap
$4.23B$994.89M
Sector
TechnologyHealth
52-Week High
$84.02$5.92
52-Week Low
$32.30$2.68
Enterprise Value
$4.04B$969.08M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Vita Coco Company Inc

COCO trades at $74.635, up 4.53% today, with a bullish technical signal and strong earnings momentum after beating Q1 2026 EPS estimates. The company reported 37% YoY revenue growth in Q1 2026, with management raising full-year guidance. Analysts maintain a $78.00 consensus price target, with 60% recommending Buy. Key support lies at $72, with resistance at $76.

Outlook remains positive driven by international expansion and dominant market position, but elevated valuation multiples pose risks. Upside depends on sustained execution against raised guidance, while any earnings miss or margin pressure could trigger volatility. The stock offers growth exposure but requires monitoring of competitive and consumer spending trends.

Sana Biotechnology Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About The Vita Coco Company Inc

The Vita Coco Company is a leading functional beverage brand specializing in coconut water. Its portfolio includes its flagship Vita Coco brand, clean energy drinks, and sustainable enhanced water products.

Read more on COCO

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA